Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v1-EN
Language English English
Date Updated 2021-06-03 2021-03-11
Drug Identification Number 02223775 02223775
Brand name NORPROLAC NORPROLAC
Common or Proper name quinagolide hydrochloride quinagolide hydrochloride
Company Name FERRING INC FERRING INC
Ingredients QUINAGOLIDE QUINAGOLIDE
Strength(s) 0.15MG 0.15MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Blister packs of 30 tablets Blister packs of 30 tablets
ATC code G02CB G02CB
ATC description OTHER GYNECOLOGICALS OTHER GYNECOLOGICALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-05-30 2021-03-31
Actual discontinuation date 2021-06-02
Remaining supply date 2021-05-30 2021-03-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments For patients, please discuss alternative treatment options with your health care professional. Norprolac starter packs are available at no cost while supplies last. Each starter pack contains 3 x 25 mcg & 3 x 50 mcg tablets. To order the Norprolac starter pack, please go to www.ferring.ca/media/1206/norprolac-starter-kit-order-form-eng.pdf and complete the form.
Health Canada comments